UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase

Journal of medicinal chemistry, 2023-09, Vol.66 (17), p.12130-12140

2023

Link zum Volltext

Verfügbarkeit prüfen

Simplified and accessible [18F]F‐AraG synthesis procedure for preclinical PET

Journal of labelled compounds & radiopharmaceuticals, 2022-08, Vol.65 (10-11), p.288-291

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

EJNMMI research, 2024-02, Vol.14 (1), p.19-19, Article 19

2024

Link zum Volltext

Verfügbarkeit prüfen

Validation of a good manufacturing practice procedure for the production of AZD4747, a CNS penetrant KRASG12c inhibitor

Journal of labelled compounds & radiopharmaceuticals, 2024-05, Vol.67 (6), p.245-249

2024

Link zum Volltext

Verfügbarkeit prüfen

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

Pharmaceuticals (Basel, Switzerland), 2022-04, Vol.15 (4), p.450

2022

Link zum Volltext

Verfügbarkeit prüfen

Modular Approach to Tricyclic Heterocycles through Copper Catalysis and Functionalization by Palladium‐Catalyzed C–H Arylation

European journal of organic chemistry, 2017-05, Vol.2017 (18), p.2610-2614

2017

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor

Nuclear medicine and biology, 2023-05, Vol.120-121, p.108349-108349, Article 108349

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor

Journal of labelled compounds & radiopharmaceuticals, 2023-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Sa2018 FIRST-TIME-IN-HUMAN VISUALISATION OF CCR9 EXPRESSION IN THE GUT BY POSITRON EMISSION TOMOGRAPHY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-605-S-605

2024

Link zum Volltext

Verfügbarkeit prüfen

Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor

Journal of labelled compounds & radiopharmaceuticals, 2024-05, Vol.67 (6), p.245

2024

Link zum Volltext

Verfügbarkeit prüfen

[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor

Nuclear medicine and biology, 2023-11, Vol.126-127, p.108437, Article 108437

2023

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S51-S52

2021

Link zum Volltext

Verfügbarkeit prüfen

SP-030 - Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors

Nuclear medicine and biology, 2021-05, Vol.96-97, p.S51-S52

2021

Link zum Volltext

Verfügbarkeit prüfen

Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand

Nuclear medicine and biology, 2023-11, Vol.126-127, p.108465, Article 108465

2023

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

Nuclear medicine and biology, 2022-05, Vol.108-109, p.S38-S39

2022

Link zum Volltext

Verfügbarkeit prüfen

O-58 - Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

Nuclear medicine and biology, 2022-05, Vol.108-109, p.S38-S39

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of Chiral (Indol-2-yl)methanamines and Insight into the Stereochemistry Protecting Effects of the 9-Phenyl-9-fluorenyl Protecting Group

European journal of organic chemistry, 2015-06, Vol.2015 (17), p.3793-3805

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Synthesis and Preclinical Evaluation of [Methylpiperazine-11C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase

Simplified and accessible [18F]F‐AraG synthesis procedure for preclinical PET

Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

Validation of a good manufacturing practice procedure for the production of AZD4747, a CNS penetrant KRASG12c inhibitor

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

Modular Approach to Tricyclic Heterocycles through Copper Catalysis and Functionalization by Palladium‐Catalyzed C–H Arylation

Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor

Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor

Sa2018 FIRST-TIME-IN-HUMAN VISUALISATION OF CCR9 EXPRESSION IN THE GUT BY POSITRON EMISSION TOMOGRAPHY

Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor

[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor

Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors

SP-030 - Synthesis and preclinical evaluation of [methylpiperazine-11C]brigatinib as a PET imaging agent for mutated EGFR and ALK positive tumors

Discovery, preclinical validation and early human imaging with [11C]AZ14193391 – the first blood-brain barrier permeable and subtype selective PARP1 PET radioligand

Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

O-58 - Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor

Synthesis of Chiral (Indol-2-yl)methanamines and Insight into the Stereochemistry Protecting Effects of the 9-Phenyl-9-fluorenyl Protecting Group

Suchergebnisse filtern